Search Thought Leadership


To refine your search select a single option or a combination of options:

reset
 

THOUGHT LEADERSHIP

Asia-China-Beijing-Skyscraper Buildings
November 03, 2021
Direct Lending Takes Off in Asia Pacific: Five Key Takeaways
Read the five key takeaways from a Latham hosted panel at the recent Debtwire Forum on ‘Direct Lending: Taking Off in Asia Pacific’.
Share
view
Displaying Thought Leadership item(s) about Healthcare & Life Sciences
1/2/3/4/5Next 230 results
 
  • November 22, 2021
     
    Pharmaceutical Capsule Latham’s Government Price Reporting Team covers general developments, the Medicaid Drug Rebate Program, the 340B Drug Pricing Program, Medicare Part B, and state law developments.
     
    Share
    view
  • November 08, 2021
     
    Pharmaceutical Capsule Latham’s Government Price Reporting Team covers general developments, the Medicaid Drug Rebate Program, the 340B Drug Pricing Program, Medicare Part B, and state law developments.
     
    Share
    view
  • October 25, 2021
     
    Pharmaceutical Capsule Latham’s Government Price Reporting Team covers general developments, the Medicaid Drug Rebate Program, the 340B Drug Pricing Program, Medicare Part B, and state law developments.
     
    Share
    view
  • October 11, 2021
     
    Pharmaceutical Capsule Latham’s Government Price Reporting Team covers general developments, the Medicaid Drug Rebate Program, the 340B Drug Pricing Program, Medicare Part B, and state law developments.
     
    Share
    view
  • September 27, 2021
     
    Pharmaceutical Capsule Latham’s Government Price Reporting Team covers general developments, the Medicaid Drug Rebate Program, the 340B Drug Pricing Program, Medicare Part B, and state law developments.
     
    Share
    view
  • September 13, 2021
     
    Pharmaceutical Capsule Latham’s Government Price Reporting Team covers general developments, the Medicaid Drug Rebate Program, the 340B Drug Pricing Program, Medicare Part B, and state law developments.
     
    Share
    view
  • August 30, 2021
     
    Pharmaceutical Capsule Latham’s Government Price Reporting Team covers general developments, the Medicaid Drug Rebate Program, the 340B Drug Pricing Program, Medicare Part B, and state law developments.
     
    Share
    view
  • August 16, 2021
     
    Pharmaceutical Capsule Latham’s Government Price Reporting Team covers general developments, the Medicaid Drug Rebate Program, the 340B Drug Pricing Program, Medicare Part B, and state law developments.
     
    Share
    view
  • August 02, 2021
     
    Pharmaceutical Capsule Latham’s Government Price Reporting Team covers general developments, the Medicaid Drug Rebate Program, the 340B Drug Pricing Program, Medicare Part B, and state law developments.
     
    Share
    view
  • July 19, 2021
     
    Pharmaceutical Capsule Latham’s Government Price Reporting Team covers general developments, the Medicaid Drug Rebate Program, the 340B Drug Pricing Program, Medicare Part B, and state law developments.
     
    Share
    view
  • July 06, 2021
     
    Pharmaceutical Capsule Latham’s Government Price Reporting Team covers general developments, the Medicaid Drug Rebate Program, the 340B Drug Pricing Program, Medicare Part B, and state law developments.
     
    Share
    view
  • June 22, 2021
     
    Pharmaceutical Capsule Latham’s Government Price Reporting Team covers general developments, the Medicaid Drug Rebate Program, the 340B Drug Pricing Program, Medicare Part B, and state law developments.
     
    Share
    view
  • June 07, 2021
     
    Pharmaceutical Capsule Latham’s Government Price Reporting Team covers general developments, the Medicaid Drug Rebate Program, the 340B Drug Pricing Program, Medicare Part B, and state law developments.
     
    Share
    view
  • May 27, 2021
     
    DNA05 In Lexology’s Getting the Deal Through: Digital Health 2021 (UK) Latham considers the key regulatory and transactional issues faced by market players and practitioners.
     
    Share
    view
  • May 24, 2021
     
    Pharmaceutical Capsule Latham’s Government Price Reporting Team covers general developments, the Medicaid Drug Rebate Program, the 340B Drug Pricing Program, Medicare Part B, and state law developments.
     
    Share
    view
  • May 10, 2021
     
    Pharmaceutical Capsule Latham’s government price reporting team covers general developments, followed by sections focusing on the Medicaid Drug Rebate Program, the 340B Drug Pricing Program, Medicare Part B, and state law developments.
     
    Share
    view
  • February 19, 2021
     
    life_sciences_003 Latham lawyers Eveline Van Keymeulen and Jeanne Fabre discuss essential rules on medicines and medical devices under the French regulatory regime, for the Life Sciences Law Review.
     
    Share
    view
 
1/2/3/4/5Next
 
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.